Statistics for TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Total visits
| views | |
|---|---|
| TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT | 66 |
Total visits per month
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
File Visits
| views | |
|---|---|
| TRIB2 confers resistance to anti-cancer therapy by activating the serine threonine protein kinase AKT.pdf | 101 |
Top country views
| views | |
|---|---|
| United States | 48 |
| Portugal | 15 |
| China | 1 |
| South Korea | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Faro | 2 |